
    
      This study is open to males and non-pregnant females, 12 years of age and over, with clinical
      signs and symptoms of tinea pedis consisting of at least moderate erythema, moderate scaling,
      mild pruritus, a positive screening KOH, and a positive culture.Subjects will be evaluated at
      Day 1 (baseline), Week 2, Week 4, and Week 6 (follow-up). Adverse events, concomitant
      medications,and study drug compliance will be reviewed at each visit. Efficacy assessments
      will include KOH and culture evaluations, clinical signs/symptoms (erythema, scaling,
      pruritus), and Investigator's Global Assessment.
    
  